throbber
1
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`2
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`3
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`4
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`5
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`6
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`7
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`8
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`9
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`10
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`11
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`12
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`13
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`14
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`15
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`16
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`17
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`18
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`19
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`20
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`Applicant(s): Robert A. Ashley
`Serial No.: 11/876,4 78
`Filed: October 22, 2007
`Page 21of34
`
`Independent Claim 46 has been added to specifically recite treating rosacea, wherein the
`
`rosacea is characterized by inflammatory lesions. The non-antibiotic tetracycline compound is
`
`administered in an amount that is effective to treat the inflammatory lesions of rosacea.
`
`Dependent Claim 4 7 recites that the inflammatory lesions are papules, pustules, nodules, or
`
`combinations thereof. Support for these claims is found in the specification at page 6, lines 29-
`
`30. Dependent Clams 48 and 49 recite specific non-antimicrobial tetracycline compounds.
`
`Independent Claim 50 has been added to specifically recite treating rosacea, wherein the
`
`rosacea is characterized by erythema. The non-antibiotic tetracycline compound is administered
`
`in an amount that is effective to treat the erythema of rosacea. Support for these claims is found
`
`in the specification at page 7, line 4. Dependent Clams 51 and 52 recite specific non(cid:173)
`
`antimicrobial tetracycline compounds.
`
`There are four sub-types of rosacea. Rosacea patients can have any one, or occasionally
`
`more than one, of these sub-types. One sub-type affects the eyes and is called "ocular rosacea."
`
`Others subtypes affect the facial skin and are herein called facial rosacea. 1 In particular,
`
`"papulopustular rosacea" is characterized by facial papules and pustules; and
`
`"erythematotelangiectatic rosacea" is mainly characterized by facial erythema. Clearly, ocular
`rosacea and facial rosacea are distinct medical conditions. 2
`
`The National Rosacea Society recently assembled a committee to develop a standard classification
`system of rosacea. Their report, authored by Wilkin, et al., appeared in J. Am. Acad. Dermatol. 46, 584-587 (2002).
`This authoritative report identified four specific sub-types of rosacea. Subtype I is called "erythematotelangiectatic
`rosacea," and is characterized by flushing and persistent central facial erythema. Subtype 2 is called
`"papulopustular rosac;ea," and is characterized by transient papules and/or pustules. Subtype 3 is called "phymatous
`rosacea," and is characterized by thickening skin, irregular surface nodularities, and enlargement, e.g., rhinophyma.
`Subtype 4 is called "ocular rosacea," and is characterized exclusively by ocular manifestations. The Wilkin report is
`attached as exhibit A.
`2
`(a) In addition to evidence provided in footnote I, facial rosacea and ocular rosacea are treated by
`physicians in different specialties with different Board certifications, i.e., dermatologists and ophthalmologists,
`respectively.
`
`(b) Moreover, the agency that approves drugs in the United States, namely the Center for Drug
`Evaluation and Research (CDER) of the Food and Drug Administration, evaluates drugs for facial rosacea and
`ocular rosacea in different divisions. Facial rosacea is evaluated in the Division of Dermatologic and Dental
`Products. Ocular rosacea is evaluated in the Division of Anti-Infection and Ophthalmologic Products. For the
`examiner's convenience, a chart of the organization of the CDER showing the separate divisions ofDermatologic
`
`21
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`22
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`23
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`24
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`25
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`26
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`27
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`28
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`29
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`30
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`31
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`32
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`33
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`34
`
`Galderma Laboratories, Inc. Ex 2014
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket